1. Home
  2. SER vs PRT Comparison

SER vs PRT Comparison

Compare SER & PRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SER
  • PRT
  • Stock Information
  • Founded
  • SER 2017
  • PRT 2017
  • Country
  • SER United States
  • PRT United States
  • Employees
  • SER N/A
  • PRT N/A
  • Industry
  • SER Biotechnology: Pharmaceutical Preparations
  • PRT Oil & Gas Production
  • Sector
  • SER Health Care
  • PRT Energy
  • Exchange
  • SER Nasdaq
  • PRT Nasdaq
  • Market Cap
  • SER 56.5M
  • PRT 48.2M
  • IPO Year
  • SER 2018
  • PRT N/A
  • Fundamental
  • Price
  • SER $5.40
  • PRT $3.98
  • Analyst Decision
  • SER Strong Buy
  • PRT
  • Analyst Count
  • SER 2
  • PRT 0
  • Target Price
  • SER $13.00
  • PRT N/A
  • AVG Volume (30 Days)
  • SER 25.7K
  • PRT 28.4K
  • Earning Date
  • SER 08-11-2025
  • PRT 08-13-2025
  • Dividend Yield
  • SER N/A
  • PRT 10.94%
  • EPS Growth
  • SER N/A
  • PRT 1.16
  • EPS
  • SER N/A
  • PRT 0.44
  • Revenue
  • SER $130,000.00
  • PRT $6,314,770.00
  • Revenue This Year
  • SER N/A
  • PRT N/A
  • Revenue Next Year
  • SER N/A
  • PRT N/A
  • P/E Ratio
  • SER N/A
  • PRT $9.04
  • Revenue Growth
  • SER N/A
  • PRT 1.82
  • 52 Week Low
  • SER $3.81
  • PRT $3.26
  • 52 Week High
  • SER $10.28
  • PRT $4.63
  • Technical
  • Relative Strength Index (RSI)
  • SER 48.70
  • PRT 45.31
  • Support Level
  • SER $5.02
  • PRT $3.95
  • Resistance Level
  • SER $5.63
  • PRT $4.05
  • Average True Range (ATR)
  • SER 0.40
  • PRT 0.07
  • MACD
  • SER 0.02
  • PRT -0.01
  • Stochastic Oscillator
  • SER 29.03
  • PRT 27.27

About SER Serina Therapeutics Inc.

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

About PRT PermRock Royalty Trust Trust Units

PermRock Royalty Trust operates as a statutory trust. Its purpose is to own the Net Profits Interest, to distribute to the Trust unitholders cash that it receives in respect of the Net Profits Interest, and to perform certain administrative functions. The Net Profits Interest entitles the trust to receive the net profits from the sale of oil and natural gas production from the underlying properties of its trustor.

Share on Social Networks: